Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
Joint Authors
Qu, Cheng-Kui
Bunting, Kevin D.
Liu, Xiaoling
Sabnis, Himalee
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-11-13
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Significant advances in our understanding of the genetic defects and the pathogenesis of juvenile myelomonocytic leukemia (JMML) have been achieved in the last several years.
The information gathered tremendously helps us in designing molecular targeted therapies for this otherwise fatal disease.
Various approaches are being investigated to target defective pathways/molecules in this disease.
However, effective therapy is still lacking.
Development of specific target-based drugs for JMML remains a big challenge and represents a promising direction in this field.
American Psychological Association (APA)
Liu, Xiaoling& Sabnis, Himalee& Bunting, Kevin D.& Qu, Cheng-Kui. 2011. Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia. Advances in Hematology،Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-462242
Modern Language Association (MLA)
Liu, Xiaoling…[et al.]. Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia. Advances in Hematology No. 2012 (2012), pp.1-7.
https://search.emarefa.net/detail/BIM-462242
American Medical Association (AMA)
Liu, Xiaoling& Sabnis, Himalee& Bunting, Kevin D.& Qu, Cheng-Kui. Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia. Advances in Hematology. 2011. Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-462242
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-462242